Voltaren and Self injurious behavior - a phase IV clinical study of FDA data

Summary:

Self injurious behavior is reported as a side effect among people who take Voltaren (diclofenac sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Fluconazole, and have Breast cancer.

The phase IV clinical study analyzes which people have Self injurious behavior when taking Voltaren. It is created by eHealthMe based on reports of 81,356 people who have side effects when taking Voltaren from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Self injurious behavior?

Self injurious behavior is found to be associated with 266 drugs and 563 conditions by eHealthMe. Check the latest studies of Self injurious behavior.

On Aug, 02, 2026

81,356 people reported to have side effects when taking Voltaren.
Among them, 37 people (0.05%) have Self injurious behavior.

Could Voltaren cause Self injurious behavior?

Among these 37 people:

How long have people been on Voltaren when they have Self injurious behavior? *

What is the gender of people who have Self injurious behavior when taking Voltaren? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Self injurious behavior when taking Voltaren? *

What are other drugs people take besides Voltaren? *

What are other side effects people have besides Self injurious behavior? *

Stress And Anxiety: 21 people, 56.76%
Insomnia (sleeplessness): 16 people, 43.24%
Diarrhea: 15 people, 40.54%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 15 people, 40.54%
Nausea And Vomiting: 15 people, 40.54%
Nausea (feeling of having an urge to vomit): 15 people, 40.54%
Eating Disorder: 14 people, 37.84%
Oedema Peripheral (superficial swelling): 14 people, 37.84%
Emotional Distress: 14 people, 37.84%
Excoriation (to tear or wear off the skin of): 14 people, 37.84%

What are the existing conditions these people have? *

Breast Cancer: 14 people, 37.84%
Fibromyalgia (a long-term condition which causes pain all over the body): 10 people, 27.03%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 10 people, 27.03%
Neuropathy Peripheral (surface nerve damage): 8 people, 21.62%
Restless Leg Syndrome (a powerful urge to move your legs): 5 people, 13.51%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.11%
Intentional Self-Injury: 3 people, 8.11%
Procedural Pain: 2 people, 5.41%
Insomnia (sleeplessness): 1 person, 2.70%
Back Pain: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and have Self injurious behavior?

- Check whether Self injurious behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Voltaren:

Voltaren (82,346 reports)

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Self injurious behavior:

Self injurious behavior (266 drugs)

Browse all the conditions that are associated with Self injurious behavior:

Self injurious behavior (563 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium (the active ingredients of Voltaren) and Voltaren (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.